Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort
This proposed CRPC definition is thought to reflect the actual biological characteristics of prostate cancer with or without upfront ARSI treatment, and it is thought that the introduction of this definition should be considered when comparing the survival outcome between with or without upfront ARSI treatment.
Authors
- Taro Igarashi (ORCID: https://orcid.org/0000-0002-5624-7614)
- Hiroki Yamada (ORCID: https://orcid.org/0000-0003-2987-7829)
- Keiichiro Miyajima (ORCID: https://orcid.org/0000-0002-7799-669X)
- Fumihiko Urabe (ORCID: https://orcid.org/0000-0002-2599-8183)
- Wataru Fukuokaya (ORCID: https://orcid.org/0000-0003-1044-912X)
- Jun Miki (ORCID: https://orcid.org/0000-0002-4638-8640)
- Tatsuya Shimomura (ORCID: https://orcid.org/0009-0008-5840-1284)
- Keiichiro Mori (ORCID: https://orcid.org/0000-0002-6147-6569)
- Masaya Murakami (ORCID: https://orcid.org/0000-0002-1268-6615)
- Takafumi Yanagisawa (ORCID: https://orcid.org/0000-0002-7410-0712)
- Kojiro Tashiro
- Sotaro Kayano (ORCID: https://orcid.org/0009-0001-0895-1551)
- Shunsuke Tsuzuki
- Yu Imai (ORCID: https://orcid.org/0000-0003-0971-4205)
- Hidetsugu Takahashi
- Katsuki Muramoto
- Kentaro Yoshihara
- Kota Katsumi
- Takahiro Kimura
- Kosuke Iwatani
Institutions
- Jikei University School of Medicine (JP)
Publication Details
- Journal
- The Prostate
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1002/pros.24898
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Jikei University School of Medicine